Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Debt Issuance
confidence 88%
filed 2026-06-23
Item 1.01
Pacific Gas & Electric amended its credit agreements on June 22, 2026, increasing aggregate commitments from $5.4 billion to $6.25 billion under Amendment No. 6 to its Credit Agreement (extending maturity to June 20, 2031) and amending its revolving credit facility (extending maturity to June 22, 2029) with modified pricing grids and collateral release terms. These material amendments expand the company's borrowing capacity and extend its debt maturity profile.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
North Haven Private Income Fund LLC completed an unregistered sale of approximately 338,864 Class S units for $6.12 million, relying on Section 4(a)(2) and Regulation D exemptions with accredited investor representations.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-23
Item 7.01
North Haven Private Income Fund LLC declared two distributions on June 22, 2026: a regular distribution of $0.1208 per unit and a special distribution of $0.0205 per unit, both payable on or around July 6, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-23
Item 2.02
Worthington Enterprises issued a news release reporting fourth quarter and full-year fiscal 2026 results, including net sales of $371.5M for Q4, net earnings of $48.1M, EPS of $0.97, segment performance, cash flow analysis, and forward guidance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-23
Item 5.02
The Board appointed W. Bradley Southern as a director effective June 23, 2026, increasing authorized directors from 13 to 14. Mr. Southern brings extensive executive experience as former CEO and Chair of Louisiana-Pacific Corporation (1999–2026) and currently serves as chair of the Nashville Federal Reserve Bank branch.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-23
Item 8.01
The Board declared a quarterly cash dividend of $0.20 per share on June 23, 2026, payable on September 29, 2026, representing a 5% increase ($0.01 per share) compared to the prior quarter.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
North Haven Private Income Fund A LLC completed an unregistered private placement of approximately 24,412 Class I units for $0.5 million at $19.81 per unit, pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-23
Item 7.01
North Haven Private Income Fund A LLC declared two distributions on June 22, 2026: a regular distribution of $0.1393 per unit and a special distribution of $0.0372 per unit, both payable on or around July 6, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Olema's June 17, 2026 annual meeting of stockholders. The filing presents final voting tallies for three proposals: election of four Class III directors (all elected), advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor. The disclosure directly matches the shareholder_vote_results event type and is material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-06-23
Item 7.01
The Board of Directors declared a quarterly cash dividend of $0.77 per share on Class A and Class B common stock, totaling approximately $127.9 million, payable on July 15, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
LGAM Private Credit LLC sold approximately 263,964 Common Units for $5.2 million at $19.61 per unit pursuant to subscription agreements, relying on Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-06-23
Item 7.01
The company declared a regular distribution to unitholders of $0.1389 per unit, payable July 6, 2026 to unitholders of record as of June 30, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 75%
filed 2026-06-23
Item 7.01
Blackstone disclosed a preliminary estimate of revenue expected to be recorded related to realization activity for the period April 1–June 23, 2026, projecting total Realized Performance Revenues and Realized Principal Investment Income in excess of $500 million. While this is an intra-quarter update rather than a full earnings release, it constitutes a material disclosure of expected financial results for a significant portion of Q2 2026, announced via press release and furnished under Item 7.01 (Regulation FD Disclosure). The disclosure materially affects investor understanding of near-term revenue generation and is consistent with earnings-related guidance.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-23
Item 5.02
The Board approved amended compensation arrangements for non-employee directors, including increases to annual cash retainers (base retainer increased $5,000 to $80,000; committee chair retainers increased $2,500–$5,000; Board Chair retainer increased $5,000 to $60,000) and restricted stock unit awards (base award increased $15,000 to $140,000; Board Chair award increased $10,000 to $70,000). This is a material compensatory arrangement disclosure under Item 5.02(e), affecting director compensation structure and equity grants.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 filing discloses the results of Apollo Debt Solutions BDC's Annual Meeting of Shareholders held on June 18, 2026, including voting outcomes for two proposals: election of two Class II Trustees and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (FOR, WITHHELD, AGAINST, ABSTAIN, BROKER-NON-VOTE) are the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-06-23
Item 1.01
NNN REIT entered into a First Amendment to its Term Loan Agreement on June 23, 2026, exercising a $200 million incremental term loan option that increases the aggregate facility size from $300 million to $500 million. This expansion of the company's senior unsecured term loan facility represents the creation of a new direct financial obligation, with amendments to pricing grids on both the term loan and revolving credit facility reflecting refinancing activity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-23
Item 5.02
Cory Anderson was promoted from Senior Vice President, Chief Technology Officer to Executive Vice President, General Manager of Greenbrook effective July 1, 2026. While the disclosure includes compensatory changes (salary increase to $425,000 and bonus target increase to 45%), the principal disclosed action is the promotion to a new executive officer role with expanded responsibilities. The appointment of a person to a higher executive position is the salient event, though the compensation component is secondary.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 disclosure reports the results of MidCap Financial Investment Corporation's Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes for two proposals: election of two Class I Directors (Pearlman and Powell) and ratification of Deloitte & Touche LLP as independent auditor. The tabulated vote counts for each proposal are the core content of the filing, making this a textbook shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 discloses the results of the 2026 Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes on four proposals: election of three directors (Tracey Benford, David M. McCoy, and Robert B. Stewart, Jr.), advisory approval of named executive officer compensation, frequency of future advisory compensation votes, and ratification of KPMG LLP as independent auditor. The filing presents vote tallies (For, Against, Withheld, Abstained, Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-23
Item 7.01
The disclosure concerns a revised, unsolicited tender offer from Zodiac Partners II to acquire all outstanding shares of DXL at $0.84 per share. The Board is actively evaluating this offer and will make a recommendation to stockholders. This constitutes a material acquisition activity (potential change of control) that would significantly affect investor assessment of the company's future, even though the offer remains unsolicited and under review.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 85%
filed 2026-06-23
EX-99.1
Obsidian Energy announced an increase in its syndicated credit facility from $235 million to $275 million, a $40 million expansion. This represents a material amendment to an existing direct financial obligation (credit facility) that enhances the company's borrowing capacity and financial flexibility. While not a new debt issuance per se, the expansion of a credit facility constitutes a material creation or amendment of a direct financial obligation, which falls under debt_issuance. The company explicitly states this strengthens its financial position ahead of the Belly River acquisition closing.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-23
Item 5.07
On June 23, 2026, Willis Lease Finance Corp stockholders approved a three-for-one forward stock split (Proposal 2) at a reconvened Annual Meeting, with 6,151,386 votes in favor, 1,187,377 against, and 6,752 abstentions. The filing also confirms approval of all five 2026 proxy proposals with overwhelming shareholder support.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-23
Item 1.01
CBRE entered into a new $1 billion 364-day senior unsecured revolving credit facility on June 23, 2026, replacing its prior facility. The facility features SOFR-based pricing, a leverage ratio covenant, and a maturity date of June 22, 2027.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-23
Item 8.01
This Item 8.01 discloses a material acquisition event: Catalyst Pharmaceuticals entered into a Merger Agreement with Angelini Pharma on May 6, 2026, providing for the merger of Angelini's subsidiary with Catalyst, with Catalyst surviving as a wholly-owned subsidiary of Angelini Pharma. The filing updates that the FTC granted early termination of the HSR Act waiting period on June 16, 2026, and the parties expect closing in Q3 2026 subject to customary conditions including stockholder approval. This is a change-of-control transaction material to any reasonable investor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
FibroBiologics held its Annual Meeting on June 22, 2026, with stockholders voting on four proposals: election of Class III director Pete O'Heeron, ratification of WithumSmith+Brown, PC as independent auditor, approval of warrant issuance under Nasdaq Rule 5635(d), and approval of the 2026 Equity and Incentive Compensation Plan. All proposals passed with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-23
Item 5.02
Stockholders approved and adopted the FibroBiologics, Inc. 2026 Equity and Incentive Compensation Plan, which authorizes 2,061,968 shares and enables the Compensation Committee to grant equity-based and cash-based compensation to employees, officers, consultants, and directors, including performance-based awards and evergreen provisions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-23
Item 5.02
The filing discloses the appointment of Robert Azelby as a director of Tango Therapeutics, effective June 19, 2026, to fill a newly created board vacancy. While the disclosure also includes compensatory arrangements (equity awards and retainers), the principal action is the appointment itself. The appointment of an experienced biopharmaceutical executive with 30+ years of industry leadership to the board of a clinical-stage biotech company is material to investors assessing the company's governance and strategic direction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of United Parks & Resorts' 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing presents detailed voting tallies for four proposals: election of ten directors, ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on say-on-pay frequency. All proposals passed with substantial majorities, making this a routine but material shareholder governance event.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-06-23
Item 8.01
Enanta disclosed an adverse Federal Circuit court ruling affirming summary judgment that invalidated claims of U.S. Patent No. 11,358,953 in its patent infringement suit against Pfizer over Paxlovid. This is a material litigation outcome involving a major pharmaceutical competitor and a core patent asset, directly affecting the Company's ability to recover damages and enforce its intellectual property rights.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-06-23
Item 8.01
Republic Services agreed to issue $700 million of 4.750% notes due 2031 and $500 million of 5.000% notes due 2036 pursuant to an Underwriting Agreement dated June 22, 2026, creating $1.2 billion in material direct financial obligations.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-06-23
EX-99.1
Equinox Gold Corp. proposed to acquire all outstanding common shares of Orla Mining Ltd. by way of a court-approved plan of arrangement, with an exchange ratio of 1.00 Equinox Gold share plus $0.0001 cash per Orla share, involving the issuance of up to 421.8 million Equinox Gold shares. The transaction, described as transformative, requires shareholder approval at a special meeting scheduled for July 22, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-23
Item 2.02
EagleRock issued a press release on June 23, 2026 disclosing preliminary pro forma financial results for the quarter ended March 31, 2026, including revenue ($29.6–$36.1 million), net income ($13.3–$16.2 million), and Adjusted EBITDA ($25.7–$31.5 million). The filing is made under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. Although the results are preliminary and unaudited pro forma figures (due to the company's recent IPO on May 15, 2026), this constitutes a material disclosure of quarterly financial results to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-23
Item 1.01
This disclosure reports Amendment No. 1 to a business combination agreement (BCA) between Eureka Acquisition Corp (SPAC), Marine Thinking Inc., and an amalgamation subsidiary, dated June 12, 2026. The amendment modifies post-closing director requirements under section 5.19 of the original BCA filed October 29, 2025. Material amendments to definitive M&A agreements constitute ma_activity under Item 1.01, as they affect the terms and conditions of the pending business combination.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-06-23
EX-99.1
This investor presentation discloses CLPS Inc's full fiscal year 2025 financial results (revenue $164.5M, net loss $(6.4)M) and H1 FY2026 interim results (revenue $85.1M, net income $0.3M), marking a return to profitability. The presentation includes detailed revenue breakdowns by service line, geography, and operational area, along with forward guidance of 10–15% revenue growth for FY2026. While formatted as a presentation rather than a traditional press release, it functions as a comprehensive earnings disclosure of material financial results and is clearly intended for investor communication.
View raw filing on EDGAR →
6-K
Other material
confidence 75%
filed 2026-06-23
EX-99.1
The press release announces a plan to implement a 1-for-25 reverse ADS split (changing the ADS ratio from 1 ADS per 18 ordinary shares to 1 ADS per 450 ordinary shares), effective June 25, 2026. While this is a capital structure event affecting the trading mechanics of the company's ADSs on NASDAQ, it does not fit neatly into the standard taxonomy categories. It is not a dilutive issuance (no new securities issued), not a dividend distribution, and not a governance matter in the traditional sense. The event is material to investors as it affects the trading price and share structure, but the specific mechanism—a reverse ADS split—does not align with any named event type, warranting classification as `other_material`.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-23
The filing discloses Item 5.02 approval by the Compensation Committee of one-time special discretionary cash bonus awards to the CEO ($250,000) and CFO ($100,000), explicitly recognizing their contributions to the Company's NYSE American listing, strategic repositioning toward AI/HPC infrastructure, and data center pipeline development. This is a compensatory arrangement for named executives, distinct from a departure or appointment.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-23
EX-99.1
This press release announces a strategic partnership between Park Ha Biological and Cloud Factory Technology Holdings to develop an AI-driven ecosystem for the beauty industry. The disclosure describes a comprehensive collaboration involving technology integration, operational efficiency improvements, and supply chain optimization. While not a traditional M&A transaction, this strategic partnership represents a material operational and business development event that would affect a reasonable investor's assessment of the company's growth strategy and competitive positioning. The partnership is characterized as "a pivotal milestone" in the company's transition to "data-driven, intelligent, and lean operational growth."
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-23
The 6-K discloses results of an extraordinary general meeting of shareholders held on June 18, 2026, with voting tallies for four distinct proposals: (1) approval of a massive increase in authorized share capital from US$20 million to US$10 billion, (2) adoption of amended memorandum of association reflecting the capital increase, (3) approval of share consolidation at a ratio between 2:1 and 250:1 at board discretion, and (4) adoption of amended memorandum and articles reflecting the consolidation. All four proposals passed with substantial majorities. These are material structural changes to the company's capitalization and governance requiring shareholder approval.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-23
EX-99.1
This press release announces a strategic partnership agreement between Youlife Group Inc. and Anhui Thingo Intelligent Technology Co., Ltd to develop AI-powered workforce solutions across three domains: AI agent business development, AI-powered recruitment systems, and vocational education partnerships. The partnership represents a material operational and strategic initiative that would affect a reasonable investor's assessment of the company's business direction and growth opportunities, particularly as management commentary emphasizes it enables evolution from a labor-intensive services provider into a human-AI collaboration platform with "substantial new revenue opportunities going forward."
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-06-23
Item 1.01
HeartSciences entered into a definitive Agreement and Plan of Merger with Fortitude Mining Holdings, Inc. on June 23, 2026, whereby Fortitude will merge with HeartSciences' subsidiary in an all-stock transaction expected to close in H2 2026. The transaction represents a material change of control, with Fortitude's parent DCG expected to own approximately 95% of the combined company post-closing and HeartSciences shareholders retaining approximately 5%, fundamentally transforming HeartSciences' business and ownership structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-23
Item 2.01
Quantum Computing Inc. completed the acquisition of NHanced Semiconductors, Inc. for $73.1 million in upfront consideration (cash and stock) plus up to $72.0 million in earnout payments. The acquisition adds semiconductor and nanophotonics fabrication capabilities and launches Fab 2 to accelerate the company's path to commercial-scale production.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-23
Item 8.01
Faraday Future announced the launch of new robotics products (the All-New Futurist humanoid robot and FF Faber mobile manipulator series) and previewed its industrial ecosystem strategy at the Automate conference in Chicago. The disclosure emphasizes product innovation, pricing ($89,900 for the Futurist), expected June shipments exceeding 100 units, and strategic expansion into industrial applications. This is a material operational and strategic business event—a significant product launch and market expansion milestone—but does not fit the specific categories of M&A, earnings release, or other named event types. The company is disclosing material progress on its core business strategy and product roadmap.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-23
EX-99.1
This press release announces receipt of follow-on orders from an existing governmental customer for Maris-Tech's edge video and AI systems. While the disclosure does not specify order value or financial impact, the announcement emphasizes repeat orders from an intelligence customer already operating the company's systems in mission-critical environments, signaling sustained customer confidence and ongoing operational deployment. This is a material business development—a significant customer contract or order—that does not fit the specific categories of earnings release, M&A activity, or other named event types, making it an operational business event.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-23
EX-99.1
This is a corporate presentation disclosing Purple Biotech's CAPTN-3 tri-specific antibody platform and pipeline progress, including preclinical data for lead program IM1240 and second program IM1305, with planned IND submission in 2027 and Phase 1 initiation in H1 2027. The presentation details the company's technology, mechanism of action, and development roadmap for immuno-oncology candidates. While this is a strategic/operational disclosure of product development milestones and platform capabilities rather than a discrete event like M&A or earnings, it represents material progress on the company's core pipeline and would affect a reasonable investor's assessment of the registrant's development trajectory and value creation potential.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Shareholders voted at the June 16, 2026 annual meeting on three proposals: setting board size at six directors, electing six director nominees (Michael McFadden, Kenneth Cawkell, Rajeev Bakshi, Phillip Mertz, Robert Wills, and Bethany Sensenig), and ratifying CBIZ CPAs P.C. as the independent auditor. All three proposals passed.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-23
Item 5.02
The Board appointed Dr. Robert Wills as non-executive Chair of the Board following the June 16, 2026 annual meeting, a material change to the registrant's senior leadership structure.
View raw filing on EDGAR →
6-K
Material Litigation
confidence 95%
filed 2026-06-23
EX-99.1
This press release discloses first-instance court rulings in patent litigation between Xiao-I's subsidiary Shanghai Xiao-I and Apple Inc. regarding alleged infringement of a chat robot patent by Apple's Siri technology. The Shanghai High People's Court dismissed Xiao-I's infringement claims and ruled that iPhone models with Siri do not infringe the patent. The Company intends to appeal to the Supreme People's Court. This is a material litigation development affecting the Company's intellectual property rights and potential financial recovery.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-23
Item 5.07
This Item 5.07 discloses the results of a Special Meeting of Stockholders held on June 23, 2026, where shareholders voted on multiple material matters: election of a Class I director (Lauren Chung), approval of a reverse stock split amendment (1-for-5 to 1-for-200 ratio), approval of convertible preferred stock issuance to Bio Insights LLC for asset acquisition, approval of potential dilutive issuance upon conversion of a promissory note to NorthView Sponsor I LLC, and amendment to the 2025 Equity and Incentive Plan. The filing presents detailed vote tallies for each proposal, which is the core disclosure required by Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-23
Item 7.01
The filing discloses the election of Li Shanglong (Michael Li) as new Chairman and the appointment of Shao Weizhi (Eric Shao) as new Chief Executive Officer, following the resignation of James Li from both CEO and Chairman roles. While the filing involves both a departure and appointments, the principal disclosed action centers on the appointment of two new senior executives to lead the company's strategic transformation. The detailed biographical information and Board's rationale for the appointments underscore their materiality to investors assessing leadership continuity and strategic direction.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-06-23
Item 8.01
SCWorx received a Nasdaq Hearings Panel decision on June 17, 2026 granting continued listing subject to strict compliance conditions: obtaining shareholder approval for a reverse stock split by July 22, 2026, effecting the split by August 3, 2026, and demonstrating a $1.00+ closing bid price for 20 consecutive trading days by August 28, 2026. Failure to meet these deadlines will result in delisting from Nasdaq. This is a material delisting-risk disclosure under Item 3.01 framework, as the company faces imminent delisting if conditions are not satisfied.
View raw filing on EDGAR →